Fri, 21 Jan 2022 15:40:56: Alnylam touts data replication for next-generation Onpattro in ATTR trial but analysts pour some cold water

Fri, 21 Jan 2022 13:00:49: MD Anderson inks deal to put Chinese cancer drugs through trials, starting with a PI3K inhibitor

Fri, 21 Jan 2022 11:37:02: Kura exits FDA clinical hold after agreeing to mitigation measures, enabling resumption of blood cancer trial 

Thu, 20 Jan 2022 13:54:28: CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet'

Thu, 20 Jan 2022 13:18:44: Fresh from $86M series A, Metis poaches Kala CSO to support move into the clinic

Thu, 20 Jan 2022 10:27:33: Bloodletting at Zymeworks as new CEO axes half of senior leaders, plans 25% reduction in headcount

Wed, 19 Jan 2022 18:56:13: Fierce JPM Week: Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm

Wed, 19 Jan 2022 17:59:44: Fierce JPM Week: As Novartis tries to avoid 'me-too' meds in M&A hunt, R&D chief urges biotechs to 'please reach out'

Wed, 19 Jan 2022 15:09:25: Charles River diving deeper into AI drug development in partnership with Valo Health

Wed, 19 Jan 2022 11:36:27: Altos bursts out of stealth with $3B, a dream team C-suite and a wildly ambitious plan to reverse disease

Wed, 19 Jan 2022 10:42:58: Barron quits GSK to take CEO post at $3B biotech startup, leaving Wood to finish what he began

Tue, 18 Jan 2022 14:07:20: Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA

Tue, 18 Jan 2022 13:26:53: With $825M SPAC merger, ProKidney sets stage for phase 3 trial of kidney disease cell therapy

Tue, 18 Jan 2022 12:38:25: Fierce JPM Week: Johnson & Johnson's JLABS—Taming the beast, while letting it roam the world

Tue, 18 Jan 2022 10:37:22: Rewind: Roche returns to phase 2 after seeing post hoc signal in failed pivotal Huntington's trial

Fri, 14 Jan 2022 15:33:14: 'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Afeyan pens first annual letter

Fri, 14 Jan 2022 14:49:46: JPM 2022: Decentralized trials, broader service offerings and novel drugs key trends in the CRO space

Fri, 14 Jan 2022 12:04:23: FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish 

Fri, 14 Jan 2022 10:47:54: EMA sets out plan to accelerate clinical trials, reduce administrative burden

Thu, 13 Jan 2022 14:04:23: FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic

Thu, 13 Jan 2022 13:27:33: Sarepta, with pivotal data in sight, dumps Lysogene gene therapy

Thu, 13 Jan 2022 13:25:22: JPM22, Day 4: Galapagos plots rebound with M&A, new CEO; Gritstone hopes for new cancer biomarker; Vertex's cystic fibrosis dominance

Thu, 13 Jan 2022 12:48:08: AstraZeneca pays Hoos-helmed Scorpion $75M to take the sting out of undruggable cancer targets

Wed, 12 Jan 2022 13:27:49: JPM22, Day 3: Intellia, Editas plan to double down on gene editing data in 2022; Roche launches smart glucose monitor

Wed, 12 Jan 2022 13:16:49: Sanofi makes $75M preclinical bet to join Roche, Novartis and more in congested Parkinson's field